After Shutdown, NSF Catching Up on Review Panels, Funding Requests

All the while, staff members are meeting daily to prepare for another possible pause in operations come mid-month.

Written byCarolyn Wilke
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: The National Science Foundation’s headquarters in Alexandria, Virginia
MARIA B. BARNES/NSF

When the US government was partially shut down for 35 days starting December 22, work at several government agencies ground to a halt, with a total of 800,000 federal employees furloughed. The National Science Foundation, one of the sidelined science agencies, is now addressing all that went undone during that time, NSF officials told reporters this morning (February 1).

During the shutdown, 111 review panels to award grant money were canceled. The panels convened again starting on Tuesday and Wednesday this week, said Erwin Gianchandani, the deputy assistant director for NSF’s computer and information science and engineering division. Some of the rescheduled panels will meet in person and others by teleconference, including those to assess submissions for the Graduate Research Fellowship Program.

Another priority is to pay out money previously awarded to grantees, said Gianchandani. On the first day ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies